OUR EXPERTISE AND SERVICES AVAILABLE IN

Nephrology

Nephrology Services

Find syndicated market insights and custom brand analyses through our services offered in the nephrology market. Spherix’s independent research is conducted by our intelligence teams in collaboration with our proprietary network of nephrologists, patients, and leading KOLs.

Indications

Specialty Physicians Point to Permanent Changes Introduced by the COVID-19 Pandemic, Highlighting the Challenges that Lie Ahead for Pharmaceutical Manufacturers

Findings from the 16th wave of Spherix Global Insights’ COVID-19 research indicate that telemedicine is firmly entrenched, industry interaction remains...

March 22, 2021

NephrologyPress Release

Groundbreaking New Research from Spherix Global Insights Leverages More Than 1,100 Patient Charts to Provide Insights on IgA Nephropathy, Focal Segmental Glomerulosclerosis, and Alport Syndrome

Spherix announces the release of three new research publications in its RealWorld Dynamix™ series, revealing patient types, treatment paradigms, and...

March 12, 2021

NephrologyPress ReleaseRheumatology

On the Heels of Recent FDA Approvals, GlaxoSmithKline’s BENLYSTA (belimumab) and Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) Emerge as Practical and Effective Tools in the Treatment of Lupus Nephritis

According to Spherix Global Insights, nephrologists and rheumatologists express measured optimism about these treatment options and seek more experience with...

March 04, 2021

NephrologyPress Release

As SGLT2 Inhibitors Create Increased Market Complexities for Chronic Kidney Disease Non-Dialysis Patients, How Quickly Will Patient Care Evolve – If at All?

According to new research published by Spherix Global Insights, the CKD non-dialysis market is poised for seismic shifts as SGLT2...

Expertise

Spherix